Therapy areas

AstraZeneca’s Imfinzi, tremelimumab fail to improve OS versus chemotherapy in bladder cancer study

AstraZeneca's Imfinzi, tremelimumab fail to improve OS versus chemotherapy in bladder cancer study

Orexo Submits Application for vorvida to the FDA to Enable Commercialization in the US

Orexo Submits Application for vorvida to the FDA to Enable Commercialization in the US

ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio...

ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million

Pfizer weighs working with BioNTech on potential coronavirus vaccine ...

Pfizer weighs working with BioNTech on potential coronavirus vaccine ...

Open Orphan: New hVIVO contract signed with a European Biotech Company

Open Orphan: New hVIVO contract signed with a European Biotech Company